US Stocks
/
Denali Therapeutics Inc. Share Price
Denali Therapeutics Inc. Share Price

Denali Therapeutics Inc. Share Price

NASDAQ: DNLI | Mid Cap
$19.45
+$0.78 (4.18%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Denali Therapeutics Inc. Stock Performance

Open
$18.56
Prev. Close
$18.68
Circuit Range
N/A
Day Range
$18.56 - $19.52
Year Range
$14.02 - $27.27
Volume
1,38,686
Average Traded
$19.30

Denali Therapeutics Inc. Share Price Today

As of 10 October 2026, Denali Therapeutics Inc.'s share price is $19.45. The stock opened at $18.56, compared to its previous close of $18.68. During today's trading session, Denali Therapeutics Inc.'s share price traded between $18.56 and $19.52, with an average price of $19.04. Over the past 52 weeks, the stock has recorded a high of $27.27 and a low of $14.02. In terms of performance, Denali Therapeutics Inc.'s share price has risen by 4.04% over the last six months and is up 19.50% on a year-on-year basis.

Denali Therapeutics Inc. Share Price Chart

$18.56$19.52
L
Show Current Price
H

Denali Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.36B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.21
Revenue (TTM)
$0.00
Return On Equity (TTM)
-61.40%
Profit Margin
N/A
Debt to Equity
0.01
Quarterly Earnings Growth YoY
-0.51%

Denali Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$3.60
Net Profit-$126.90-$128.55-$129.81-$127.55
Net Profit MarginN/AN/AN/A-3543.06%
Income ChangeN/A-1.30%-0.98%1.74%

Denali Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$108.46$330.53$0.00$0.00
Net Profit-$325.99-$145.22-$422.77-$512.54
Net Profit Margin-300.56%-43.94%N/AN/A
Income ChangeN/A55.45%-191.12%-21.23%

About Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Denali Therapeutics Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$20.57
$19.45
-6.13%
Sep 2026
$23.59
$20.73
-15.97%
Aug 2026
$22.80
$24.66
+7.19%
Jul 2026
$25.83
$23.01
-10.54%
Jun 2026
$20.86
$25.72
+22.30%
May 2026
$18.53
$21.03
+12.46%
Apr 2026
$19.57
$18.70
-2.50%
Mar 2026
$21.07
$19.18
-9.46%
Feb 2026
$21.27
$21.18
-2.69%
Jan 2026
$16.57
$21.77
+31.86%
Dec 2025
$19.13
$16.51
-15.20%
Nov 2025
$16.12
$19.47
+19.59%

DNLI Share Price FAQs

What is Denali Therapeutics Inc. share price today?

chevron-up
Denali Therapeutics Inc. share price today is $19.45 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Denali Therapeutics Inc. stock?

chevron-up
The 52 week high of Denali Therapeutics Inc. stock is $27.27, while the 52 week low is $14.02 as of 10 Oct '26.

What is DNLI's market capitalisation today?

chevron-up
DNLI market capitalisation is $3.36B as of October 10, 2026, at 4:40 am IST.

What is DNLI's net income for the last quarter?

chevron-up
DNLI's net income for the last quarter is -127.55B USD.

What is the 5 year returns of DNLI?

chevron-up
The 5 year returns of DNLI is -59.76% as on 10 Oct '26.

What is the high & low stock price of DNLI today?

chevron-up
DNLI stock price hit a high of $19.52 and low of $18.56 as of 10 Oct '26.

Can I buy DNLI shares in India?

chevron-up
Yes. You can buy DNLI in India by opening an international trading account.